Micron’s stock gains, signaling a ‘return to optimism’ about the chip sector

The Securities and Exchange Commission today proposed Regulation E-Delivery, a new rule that would expand the ability of issuers, broker-dealers, investment advisers, and others to use electronic delivery to satisfy information delivery requirements under the federal securities laws.  Regulation E-Delivery would make information more readily accessible and useful for investors and others while preserving the ability…

Accounting practice management solutions provider Firm360, in partnership with tax prep software company Juno, announced Firm360 AutoPrep, for firms doing tax prep on major tax software. Processing Content AutoPrep takes the client tax documents firms already collected in Firm360 and turns them into entered, verified data in their tax software, with no manual typing. Firms…

Behind the scenes of the making of a dance getty It all started with a dance challenge by a few popular K-pop artists set to the song “GG EZ” by M.Sasuke. The song, named after a gaming term, was light, electronic pop with a catchy hook and sounds that made it easy to choreograph a…

Editor’s note: Lynlee Brown is a partner in global trade at Ernst & Young based in San Diego. Views are the author’s own. As the U.S. tariff and refund environment and processes evolve, how companies handle their specific situations at the outset could have complex and potentially irreversible downstream implications. A lack of cross-functional coordination, inconsistent…

Mitsubishi officially became one of the largest natural gas producers in the U.S. on Wednesday, following a $7.5 billion deal that positions the Japanese giant to benefit from the surge in gas exports—especially to Japan—as well as from the AI data center boom that increasingly thirsts for more gas-fired power. Mitsubishi closed on its largest…

Shares of Q32 Bio (QTTB +90.72%) soared on Monday after the biotechnology company announced promising clinical trial results for its experimental hair loss treatment. Image source: Getty Images. Encouraging data A Phase 2a clinical study of Q32 Bio’s investigational antibody treatment, bempikibart, in patients with severe or very severe alopecia areata met its primary efficacy…